Greatly Health Closes $4M Seed to Bring MSK-Validated Integrative Oncology to Cancer Patients Everywhere

Photo Credit: Greatly Health

When Greatly Health, a healthtech company delivering evidence-based integrative oncology at scale, was referred to MAG PR by Pear VC ahead of their $4 million seed funding announcement, the company was sitting on one of the most compelling clinical stories in early-stage healthcare. Co-founded by digital health executive Chip Stine alongside Dr. Jun Mao, Chief of Integrative Medicine and Wellness at Memorial Sloan Kettering Cancer Center (MSK), and Dr. Robert Daly, Associate Attending Physician at MSK, Greatly's virtual care model was originally developed and clinically validated at MSK, where a randomized trial demonstrated a 16% absolute improvement in overall survival at two years compared to usual care.

In other words, this is not a theoretical model. It works, it's been proven, and it has the data to back it up. The challenge was making sure the right audiences heard the story.

With a co-led round from Pear VC and Commonweal Ventures, additional participation from Flare Capital Partners, an MSK-validated clinical foundation, and a mission to shift integrative oncology from an out-of-pocket service to a reimbursed standard of care, the team had every ingredient for a breakout announcement. They came to MAG PR for a focused 30-day program with a clear ask, which was to secure 2-3 quality earned media opportunities across funding and healthcare media…We delivered 10.

The Challenge: Translating a Complex Clinical Story for Multiple Audiences

Integrative oncology sits at an unusual intersection. There's a rigorous clinical category backed by trial data, a business story tied to a $200B+ market and growing federal interest (CMS's recent MAHA ELEVATE initiative was a notable tailwind), and a deeply human story about cancer patients and the symptom burden they face during treatment.

Greatly's announcement also carried a layer of complexity that required careful coordination across their institutional partners and investors.  Our team worked closely with Chip and Greatly's broader investor base, including Pear, to pull the story together in a way that honored every stakeholder.

We also needed to secure coverage that resonated across multiple verticals at once, including funding and business media, healthcare trades, and digital health publications.

Our Strategy: Multi-Vertical Embargo Outreach + Stakeholder Coordination

Working in lockstep with Chip and the Greatly team, MAG PR built an embargo-driven media strategy designed to maximize reach across every priority audience within a tight 30-day window. Our approach included:

  • Story Architecture and Stakeholder Alignment. Before any pitching began, our team helped bring the broader group together, working across Greatly, Pear VC, and other key voices to lock in messaging and investor quotes

  • Tiered Embargo Outreach. We built a precision-targeted media list spanning four verticals, including funding and business, healthcare and healthtech, digital health, and oncology. We pre-pitched under embargo to give priority journalists the time they needed to dig into the clinical data and craft thoughtful coverage.

  • Day-of Coordination and Full-Court Press. Once the embargo lifted, we executed a coordinated push across our broader media list, building on the momentum from initial coverage to drive additional pickups.

  • A Layer of Thought Leadership. Recognizing that funding news is just the beginning, we layered in a co-authored contributed article opportunity to extend the brand's voice beyond the announcement window and position Chip and Dr. Mao as emerging thought leaders in the integrative oncology space.

Key Outcomes: 10 Total Hits, Way Over the Goal Line

Against a target of 2-3 quality placements, MAG PR landed 9 earned press hits plus 1 contributed article placement opportunity for a total of 10 across top funding and healthcare media:

  • Crain's New York Business

  • WSJ VC Pro (2 mentions)

  • HIT Consultant

  • Fierce Healthcare

  • Rock Health

  • Startup Health

  • Pulse 2.0

  • CityBiz

  • Healthcare Business Today 

The campaign hit every key audience Greatly needed to reach. Crain's New York Business validated the company's footprint in the NYC healthcare/business community. HIT Consultant and Fierce Healthcare delivered credibility with healthcare decision-makers. WSJ VC Pro, Rock Health, and Startup Health drove visibility across the funding and digital health investor community. And Pulse 2.0 and CityBiz added strong, comprehensive deep-dives into the startup model itself.

A Story Just Getting Started

Greatly Health is taking on one of the most important access gaps in modern oncology, and they're doing it with a clinical foundation that's hard to argue with. By bringing all the right voices together and executing a tight embargo strategy across four target verticals, MAG PR helped Greatly turn its seed announcement into a meaningful inflection moment in a short 30-day window.

Launching a company like Greatly means working through a lot of moving parts. The MAG PR team handled all of it with care and got our story in front of the right reporters at the right outlets. The coverage they landed gave us real momentum heading into this next chapter.
— Chip Stine, Co-Founder & CEO, Greatly Health